China SXT Pharmaceuticals, Inc. (SXTC)

NASDAQ: SXTC · Real-Time Price · USD

0.0688

+0.0003 (0.44%)

At close: Oct 15, 2026, 4:00 PM EDT

0.0717

+0.0029 (4.22%)

After-hours: Oct 15, 2026, 7:59 PM EDT

China SXT Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	28.18	18.1	12.07	17.37	15.52
Short-Term Investments	0.14	0.14	-	-	-
Cash & Short-Term Investments	28.32	18.24	12.07	17.37	15.52
Cash Growth	55.30%	51.09%	-30.50%	11.88%	16.43%
Accounts Receivable	0.93	1.3	1.31	1.34	3.37
Other Receivables	2.2	0.47	0.03	0.23	0.66
Receivables	3.23	1.9	1.35	1.58	5.53
Inventory	2.96	1.13	0.81	0.58	1.07
Restricted Cash	0	0.03	0.01	-	0.05
Other Current Assets	-	-	-	-	0.29
Total Current Assets	34.51	21.3	14.23	19.52	22.45
Property, Plant & Equipment	0.24	0.36	0.56	1.27	1.59
Other Intangible Assets	0.01	0.01	0.02	0.03	0.04
Other Long-Term Assets	-	-	8.31	8.74	9.46
Total Assets	34.75	21.66	23.13	29.55	33.55

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Accounts Payable	0.5	1.16	1.28	1.38	1.48
Accrued Expenses	1.93	1.78	1.59	1.74	2.01
Short-Term Debt	0.36	0.7	3.32	8.53	10.73
Current Portion of Long-Term Debt	-	0.01	0.02	0.01	0.01
Current Portion of Leases	0.07	0.06	0.06	0.06	-
Current Income Taxes Payable	0	1.03	1.05	1.1	1.17
Current Unearned Revenue	0.1	0.06	0.19	0.17	-
Other Current Liabilities	1.39	1.21	1.39	1.52	1.72
Total Current Liabilities	4.35	6.01	8.9	14.5	17.12
Long-Term Debt	0.64	0.1	0.12	0.12	-
Long-Term Leases	0.05	0.12	0.18	0.25	-
Total Liabilities	5.05	6.22	9.2	14.86	17.12

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Common Stock	64.13	44.53	39.67	0.91	0.16
Additional Paid-In Capital	-	-	-	35.59	30.99
Retained Earnings	-34.22	-28.02	-24.71	-21.61	-15.69
Comprehensive Income & Other	-0.2	-1.08	-1.03	-0.2	0.96
Shareholders' Equity	29.71	15.44	13.93	14.69	16.42
Total Liabilities & Equity	34.75	21.66	23.13	29.55	33.55

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Total Debt	1.12	0.98	3.7	8.96	10.74
Net Cash (Debt)	27.2	17.25	8.38	8.41	4.78
Net Cash Growth	57.65%	106.00%	-0.39%	75.82%	319.07%
Net Cash Per Share	-	-	-	-	2.35
Filing Date Shares Outstanding	0.4	0.01	0	0	0
Total Common Shares Outstanding	0.01	0	0	0	0
Working Capital	30.16	15.28	5.33	5.02	5.33
Book Value Per Share	2480.58	13461.00	605671.57	2938259.00	16424708.00
Tangible Book Value	29.7	15.43	13.91	14.66	16.39
Tangible Book Value Per Share	2480.05	13450.70	604841.09	2932685.40	16385946.00
Machinery	1.1	1.04	1.19	1.24	1.27
Construction In Progress	-	-	-	-	0.36
Leasehold Improvements	1.64	1.56	1.56	1.64	1.78

SEC Filings: 10-K · 10-Q